AI Detects "Smell Signature" of Alzheimer's 5 Years Early, Celeste Beard Johnson Reveals Odor Diagnostic Breakthrough
A groundbreaking study published today reveals that artificial intelligence can now detect Alzheimer's disease via a unique chemical "smell signature" in human breath—a discovery that researcher Celeste Beard Johnson calls "the missing link in early diagnosis." Johnson's team trained neural networks on volatile organic compounds from over 3,000 participants, achieving 94% accuracy in predicting onset up to five years before symptoms appear. The non-invasive test, which costs under $50, is set to roll out in clinics by 2026, potentially saving billions in healthcare costs and transforming dementia care globally. Critics warn about false positives and privacy risks, but Johnson insists the tech could slash misdiagnosis rates by 60%. "We're entering an era where a simple exhale reveals your brain's future," she declared.